Evidence map›Paper›PMID 42561154›Full record

ArticleBriefings in bioinformatics2026

Exploring cell-type associations of rare disease phenotypes using non-diseased cell atlases.

Jorge Novoa, Florencio Pazos, Monica Chagoyen

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jorge NovoaComputational Systems Biology Group. National Center for Biotechnology (CNB-CSIC), Darwin 3, 28049 Madrid, Spain.
Florencio PazosComputational Systems Biology Group. National Center for Biotechnology (CNB-CSIC), Darwin 3, 28049 Madrid, Spain.ORCID 0000-0002-2646-6226
Monica ChagoyenSystems Biomedicine Lab. Cajal Neuroscience Center (CNC-CSIC), Avda. de Leon 1, 28805 Alcala de Henares, Spain.ORCID 0000-0001-6911-1591

Funding

ERDF/EU PID2022-140017OB-C22
6 · The paper itself

Abstract

Rare diseases individually affect few patients but collectively impose a substantial global health burden. Many have a genetic origin, yet the cellular contexts in which disease genes exert their effects often remain unclear. Direct molecular investigation of disease-relevant tissues is often infeasible owing to small patient populations and frequent congenital or pediatric onset, limiting access to patient-derived samples. Here we investigate whether existing healthy human single-cell atlases can help identify candidate cellular contexts associated with rare disease phenotypes. Specifically, we test the hypothesis that cells expressing more genes linked to a phenotype than expected from their overall transcriptional activity may represent contexts particularly susceptible to disruption. Applied to more than 1300 phenotypes across multiple tissues, the analysis shows partial concordance with literature-derived phenotype-cell type relationships, with predictive performance reaching AUC ≈ 0.71 depending on the dataset. These findings suggest that transcriptional patterns captured in healthy single-cell atlases may contain informative signals about disease-relevant cellular contexts when the relevant cell populations are represented. At the same time, the results highlight the limitations of current reference resources and the need for continued efforts to improve single-cell atlases, phenotype-tissue mappings, and benchmarking datasets linking rare disease phenotypes to cellular contexts.

Indexed as

Rare DiseasesSingle-Cell AnalysisHumansPhenotypehuman cell atlasesrare diseasesscRNA-seq

Identifiers

PMID42561154
PMCPMC13446510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.